Private Foundation

XenoTherapeutics Inc

Based in Manchester, NH, XenoTherapeutics Inc operates as a Private Foundation. The organization reported $4.2M in revenue, $3.1M in expenses, $1.8M in total assets for fiscal year 2024.

EIN: 811016095 Manchester, NH Latest filing: 2024

Total Revenue$4.2M

Total Expenses$3.1M

Total Assets$1.8M

Grants Given0

Filing Years2020–2024

Officers & Directors

Clerk Dr Dicken Ko

Treasurer & CFO Jamie Love

President & CEO Jon Adkins

Trustee Mark Nedelman

Trustee Ruta Laukien

Chairman William Deacon

Officer compensation and complete director data available with membership.

Financial Trends

Year	Revenue	Expenses	Assets
2024	$4.2M	$3.1M	$1.8M
2023	$1.5M	$1.3M	$720K
2022	$990K	$1.0M	$593K
2020	$637K	$664K	$128K

Between 2020 and 2024, reported annual revenue grew from $637K to $4.2M (+563%), with total assets most recently reported at $1.8M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for XenoTherapeutics Inc

Complete financials, all 0 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 498,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports